Saul Ashley

M.S. Biomedical Data Science

Development of Anxiety in Breast Cancer Patients Undergoing Therapy: A Preliminary Study Using NIH All of Us Data

Sources report that, 1 in 8 women in the United States will be diagnosed with breast cancer in her lifetime. Furthermore, the long-term mental health outcomes of radiation therapy and chemotherapy, a common practice in the field of oncology, for cancer patients are a significant concern. Research shows that the global prevalence of anxiety among cancer patients is 17%–69%, and the global prevalence of anxiety among the general population is 31.9%, implying that the mental health outcome may be more prevalent among cancer patients. More specifically, Living Beyond Breast Cancer (LBBC) states more than 40% of people diagnosed with breast cancer experience anxiety. Even survivors may face long-term psychological effects such as anxiety, depression, and a fear of cancer recurrence, which can impact their day-to-day life. Finally, the American Cancer Society (ACS) states some cancer treatments can cause cognitive effects in current patients and survivors, such as “chemo brain” or brain fog, which may lead to difficulties with concentration, memory, and multitasking. Using NIH All of Us data, This study seeks to further highlight and examine the associations between cancer therapy and procedures and the mental health outcome of anxiety as it relates to breast cancer patients using various regression techniques.